We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+48.85%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$634M
AUM Growth
+$33.5M
(+5.6%)
Cap. Flow
-$90.2M
Cap. Flow
% of AUM
-14.22%
Top 10 Holdings %
Top 10 Hldgs %
8.15%
Holding
413
New
130
Increased
19
Reduced
118
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivePerson
LPSN
|
+$4.19M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$4.14M |
| 3 |
TBCH
Turtle Beach Corp
TBCH
|
+$4.13M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$4.07M |
| 5 |
Tactile Systems Technology
TCMD
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$6.81M |
| 2 |
CUTR
Cutera, Inc.
CUTR
|
+$4.92M |
| 3 |
Vericel Corp
VCEL
|
+$4.77M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$4.75M |
| 5 |
INST
Instructure, Inc.
INST
|
+$4.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Technology | 24.9% |
| 3 | Consumer Discretionary | 14.4% |
| 4 | Industrials | 10.81% |
| 5 | Financials | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NovoCure
NVCR
$1.73B
| $3.19M | 0.5% |
+101,773
| New | +$2.83M |
|
|
ZGNX
77
DELISTED
Zogenix, Inc.
ZGNX
| $3.17M | 0.5% |
71,718
-10,630
| -13% | -$438K |
|
78
FirstCash
FCFS
$8.85B
| $3.17M | 0.5% |
35,236
-3,546
| -9% | -$314K |
|
79
Medifast
MED
$109M
| $3.16M | 0.5% |
19,729
-21,044
| -52% | -$2.69M |
|
80
Deckers Outdoor
DECK
$13.2B
| $3.15M | 0.5% |
+167,496
| New | +$2.9M |
|
81
HubSpot
HUBS
$12.2B
| $3.14M | 0.5% |
25,058
-7,319
| -23% | -$867K |
|
82
Ligand Pharmaceuticals
LGND
$5.76B
| $3.12M | 0.49% |
24,151
-9,539
| -28% | -$1.06M |
|
|
CALY
83
Callaway Golf Company
CALY
$3.32B
| $3.12M | 0.49% |
+164,451
| New | +$3.01M |
|
84
Urban Outfitters
URBN
$6.35B
| $3.1M | 0.49% |
+69,697
| New | +$2.91M |
|
|
CSOD
85
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $3.09M | 0.49% |
+65,231
| New | +$3.05M |
|
86
HealthEquity
HQY
$8.41B
| $3.07M | 0.48% |
40,850
-9,757
| -19% | -$701K |
|
87
American Eagle Outfitters
AEO
$2.88B
| $3.06M | 0.48% |
+131,465
| New | +$2.92M |
|
88
Mammoth Energy Services
TUSK
$128M
| $3.05M | 0.48% |
89,880
+29,779
| +50% | +$1.05M |
|
|
HOME
89
DELISTED
At Home Group Inc.
HOME
| $3.05M | 0.48% |
77,968
-7,834
| -9% | -$281K |
|
|
CURO
90
DELISTED
CURO Group Holdings Corp.
CURO
| $3.05M | 0.48% |
+122,287
| New | +$2.69M |
|
91
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $3.04M | 0.48% |
+96,192
| New | +$2.86M |
|
92
Inogen
INGN
$175M
| $3.01M | 0.47% |
16,163
-9,053
| -36% | -$1.51M |
|
93
Brunswick
BC
$5.13B
| $3M | 0.47% |
+46,532
| New | +$2.9M |
|
|
AXON
94
Axon Enterprise
AXON
$42.5B
| $2.99M | 0.47% |
47,274
-33,770
| -42% | -$1.83M |
|
95
FTI Consulting
FCN
$4.4B
| $2.96M | 0.47% |
+48,853
| New | +$2.83M |
|
|
AVTA
96
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.94M | 0.46% |
+79,478
| New | +$2.56M |
|
97
Carvana
CVNA
$68.6B
| $2.93M | 0.46% |
+352,570
| New | +$2.12M |
|
|
LOXO
98
DELISTED
Loxo Oncology, Inc
LOXO
| $2.93M | 0.46% |
16,903
-7,962
| -32% | -$1.2M |
|
|
CRZO
99
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $2.93M | 0.46% |
+105,251
| New | +$2.43M |
|
|
AZPN
100
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.93M | 0.46% |
+31,580
| New | +$2.93M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2018 Portfolio in Review
As of Q2 2018, EAM Investors held 413 positions worth $634M, up 5.6% from $601M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
EAM Investors withdrew a net $90.2M in Q2 2018, closing 127 positions and reducing 118 holdings. Its most notable exit was Nektar Therapeutics, an estimated $6.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in LivePerson worth $4.69M.
- EAM Investors's largest Q2 2018 buy was LivePerson: 14,807 shares worth $4.69M.
- EAM Investors added most to Malibu Boats in Q2 2018, an estimated $3.06M increase.
- EAM Investors's biggest Q2 2018 reduction was Vericel Corp, cutting an estimated $4.77M.
- EAM Investors fully exited Nektar Therapeutics in Q2 2018, selling an estimated $6.81M.
- EAM Investors's ten largest holdings make up 8.1% of its $634M portfolio in Q2 2018.
- EAM Investors opened 130 new positions and closed 127 in Q2 2018.
- EAM Investors's portfolio value rose 5.6% quarter-over-quarter to $634M.
Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.